This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Semaglutide nausea is common: About 20 percent of Ozempic® ...

How Long It Lasts and Tips to Reduce It This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

Novo Nordisk A/S (NYSE: NVO) on Monday shared headline results from the REIMAGINE 2 phase 3 trial from the global REIMAGINE clinical trial program. REIMAGINE 2 was a 68-week efficacy and safety trial ...

As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings.

Researchers analyzed nearly 8,000 patients stopping semaglutide or tirzepatide. Most patients maintained weight or continued losing weight after one year, often by restarting therapy, switching ...